Enzyme histochemical study of germanium dioxide-induced mitochondrial myopathy in rats

Yonsei Medical Journal

Volumn 40, Issue 1, 1999, Pages 69-75

  Yim, Shin Young ^a   Lee, Il Yung ^a   Kim, Tai Seung ^b  

^a Ajou University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cytochrome c oxidase; Germanium dioxide; Mitochondrial myopathy; Oxidative metabolism; Ragged red fibers

Indexed keywords

CYTOCHROME C OXIDASE; GERMANIUM DIOXIDE; SUCCINATE DEHYDROGENASE;

AEROBIC METABOLISM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME HISTOCHEMISTRY; FEMALE; HISTOPATHOLOGY; MACROPHAGE MIGRATION; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE ATROPHY; MUSCLE NECROSIS; NONHUMAN; PATHOPHYSIOLOGY; RAT; SOLEUS MUSCLE;

EID: 2442722918     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1999.40.1.69     Document Type: Article

References (20)

1. Goodman S. Therapeutic effects of organic germanium. Med Hypotheses 1988;26:207-15.
2. Rosenfeld G. Studies of the metabolism of germanium. Arch Biochem Biophys 1954;48:84-94.
3. Schroeder HA, Balassa JJ. Abnormal trace elements in man: Germanium. J Chronic Dis 1967;20:211-24.
4. Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ishida N. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol Immunol 1985;29:65-74.
5. Budman DR, Schulman P. Vinciguerra V, Degnan TJ. Phase I trial of spirogermanium given by infusion in a multiple-dose schedule. Cancer Treat Rep 1982;66:173-5.
6. Falkson G, Falkson HC. Phase II trial of spirogermanium for treatment of advanced breast cancer. Cancer Treat Rep 1983;67:189-90.
7. Fukazawa H, Ohashi Y, Sekiyama S, Hoshi H, Abe M, Takahashi M, et al. Multidisciplinary treatment of head and neck cancer using BCG, OK-432, and Ge-132 as biologic response modifiers. Head Neck 1994;16:30-8.
8. Jang JJ, Cho KJ, Lee YS, Bae JH. Modifying responses of alkyl sulfide, indol-3-carbinol and germanium in a rat multi-organ carcinogenesis model. Carcinogenesis 1991; 12:691-5.
9. Legha S, Ajani J, Bodey G. Phase I study of spirogermanium given daily. J Clin Oncol 1983;1:-331-6.
10. Sanai T, Onoyama K, Osato S, Motomura K, Oochi N, Oh Y, et al. Dose dependency of germanium-dioxide-induced nephrotoxicity in rats. Nephron 1991;57:349-54.
11. Tsutsui M, Kakimoto N, Axtell DD, Oikawa H, Asai K. Crystal structure of "carboxyethylgermanium sesquioxide". J Am Chem Soc 1976;98:8287-9.
12. Krapf R, Schaffner T, Iten PX. Abuse of germanium associated with fatal lactic acidosis. Nephron 1992;62: 351-6.
13. Stricker BHC. Dietary germanium supplements. Lancet 1991;337:864-4.
14. van der Spoel JI, Stricker BHC, Esseveld MR, Schipper ME. Dangers of dietary germanium supplements. Lancet 1990;336:117-7.
15. Takeuchi A, Yoshizawa N, Oshima S, Kubota T, Oshikawa Y, Akashi Y, et al. Nephrotoxicity of germanium compounds: report of a case and review of the literature. Nephron 1992;60:436-42.
16. Higuchi I, Izumo S, Kuriyama M, Suehara M, Nakagawa M, Fukunaga H, et al. Germanium myopathy: clinical and experimental pathological studies. Acta Neuropathol 1989; 79:300-4.
17. Matsusaka T, Fujii M, Nakano T, Terai T, Kurata A, Imaizumi M, et al. Germanium-induced nephropathy-report of two cases and review of the literature. Clin Nephrol 1988;30:341-5.
18. Nagata N, Yoneyama T, Yanagida K, Ushio K, Yanagihara S, Matsubara O, et al. Accumulation of germanium preparation died of acute renal failure. J Toxicol Sci 1985; 10:333-41.
19. Higuchi I, Takahashi K, Nakahara K, Izumo S, Nakagawa M, Osame M. Experimental germanium myopathy. Acta Neuropathol 1991;82:55-9.
20. 10 administration. Muscle Nerve 1992;15:1258-64.